Funding

Torrey Pines Medicine

China · Biotech · Healthtech · Enterprise software

Develops ultra-long-acting peptide therapeutics for obesity, diabetes, and metabolic diseases

Funding history

Funding history

1 round · 0 with disclosed amounts
AnnouncedRoundAmountInvestors
Pre-SeedUndisclosedBlue Ocean Capital — Role not disclosedLotus Lake Ventures — Role not disclosedMr. Yousheng Shen — Role not disclosedStars Capital — Role not disclosedTainuo Capital — Role not disclosed

Investors

Blue Ocean CapitalPre-SeedLotus Lake VenturesPre-SeedMr. Yousheng ShenPre-SeedStars CapitalPre-SeedTainuo CapitalPre-Seed

Coverage

Jul 28, 2026Torrey Pines Medicine · Pre-Seed

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E